FDA Names New Drugs & Labeling Compliance Division Director
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA New Drugs & Labeling Compliance Division Acting Director Steven Silverman will assume the role on a permanent basis, FDA announced Feb. 5